Mission statement · Company scope
“Our mission is to develop innovative, transformative therapies for patients with devastating diseases through the use of our novel chRDNA genome-editing technology.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Impact · Product offering
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Technical
- Length
- 22 words · reading grade 17.5
- Review status
- auto accepted · classifier rules-v0
- Quality score
- 0.77
- Record
- st_88356db7be96f9cd
- Classification confidence
- 0.95
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-05 · sec_sentence · 10-K · accession 0001619856-26-000008
View filing ↗0 to compareCompare